BusinessEmergent BioSolutions Provides Update on Status of BioThrax Procurement Contract and Discussions With CDCBy Nasdaq OMXSep 30, 2016, 1:28 PM UTC
BusinessCell Culture Market to be Worth US$11.3 Billion in 2022; Growing Demand for Artificial Organs to Pave Way for Market’s Growth: TMRBy Nasdaq OMXSep 29, 2016, 12:45 PM UTC
BusinessForward Pharma CFO to Participate in Two Investor Conferences in FebruaryBy Nasdaq OMXFeb 9, 2016, 2:23 PM UTC
BusinessMatinas BioPharma Commences Patient Enrollment in NIH-Sponsored Phase 2a Study With MAT2203 - Oral Encochleated Amphotericin BBy Nasdaq OMXFeb 8, 2016, 12:05 PM UTC
BusinessU.S. Food and Drug Administration (FDA) Grants Breakthrough Therapy Designation to Immunomedics for Sacituzumab Govitecan for the Treatment of Patients With Triple-Negative Breast CancerBy Nasdaq OMXFeb 5, 2016, 2:28 PM UTC
